Examkin

Question

Difficulty: MediumChildhood and Neurodevelopmental Disorders

Match each of the following clinical presentations of childhood psychiatric and neurodevelopmental conditions with the cellular mechanism of action of its indicated first-line pharmacotherapy.

  • A 7-year-old boy with academic underperformance who frequently blurts out answers, leaves his seat during class, and interrupts peers. Parent and teacher behavioral interventions have been unsuccessful.Inhibition of presynaptic dopamine and norepinephrine reuptake
  • An 11-year-old boy with a two-year history of repetitive facial grimacing, shoulder shrugging, and involuntary grunting sounds that cause significant distress. Comprehensive behavioral intervention has failed.Agonism of central presynaptic alpha-2 adrenergic receptors
  • A 6-year-old boy who voids in his bed four nights a week and has never achieved nighttime dryness. A trial of a bedwetting alarm and evening fluid restriction for four months has not improved symptoms.Activation of antidiuretic hormone V2 receptors in the renal collecting duct
  • A 9-year-old boy with significant social communication deficits and stereotyped hand-flapping who recently developed severe, self-injurious head-banging and physical aggression refractory to behavioral modifications.Antagonism of central dopamine D2 and serotonin 5-HT2A receptors

Answer

ADHD is managed with stimulants (dopamine/norepinephrine reuptake inhibition). Tourette syndrome is managed with alpha-2 agonists (central presynaptic alpha-2 agonism). Enuresis is managed with desmopressin (V2 receptor activation). ASD-associated severe irritability is managed with atypical antipsychotics (D2 and 5-HT2A antagonism).
Each clinical scenario requires a three-step deduction: confirming the diagnosis, identifying the guideline-directed first-line medication post-behavioral failure, and recognizing that medication's specific mechanism of action.

Step-by-Step Solution

1
Diagnose the underlying neurodevelopmental or behavioral condition based on the specific clinical criteria presented in each vignette.
Identified ADHD, Tourette syndrome, primary nocturnal enuresis, and ASD with severe irritability.
Accurate diagnosis is the mandatory first step before considering pharmacological management.
2
Determine the most appropriate first-line medication for each condition, acknowledging that conservative or behavioral therapies have already failed in these scenarios.
Selected stimulants (ADHD), alpha-2 agonists (Tourette), desmopressin (enuresis), and atypical antipsychotics (ASD irritability).
Clinical guidelines dictate specific pharmacological escalations when behavioral interventions are inadequate.
3
Match each selected medication to its corresponding cellular mechanism of action.
Matched each drug class to its receptor or transporter target.
Understanding the pharmacodynamic properties of psychotropic drugs is essential for anticipating therapeutic effects and side effect profiles.

Key Concept

Pharmacological management of childhood neurodevelopmental disorders requires correlating specific diagnostic symptom clusters with targeted neurochemical interventions once behavioral therapies are exhausted.
Rate this question

Topics

Childhood and Neurodevelopmental Disorders

More questions from this topic